These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14831493)

  • 21. [Evaluation of the Chromotitre EIA test in the diagnosis of human brucellosis].
    Colmenero JD; Porras J; Cárdenas A; Ocón P; Reguera JM; Delgado M; Sedeño J
    Enferm Infecc Microbiol Clin; 1994 Feb; 12(2):60-5. PubMed ID: 7516713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human brucellosis in the People's Republic of China during 2005-2010.
    Zhong Z; Yu S; Wang X; Dong S; Xu J; Wang Y; Chen Z; Ren Z; Peng G
    Int J Infect Dis; 2013 May; 17(5):e289-92. PubMed ID: 23462301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brucella melitensis VirB12 recombinant protein is a potential marker for serodiagnosis of human brucellosis.
    Mirkalantari S; Zarnani AH; Nazari M; Irajian GR; Amirmozafari N
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):8. PubMed ID: 28253917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ON THE PRESENT STATUS OF BRUCELLOSIS AND THE POSSIBILITIES OF HUMAN INFECTIONS].
    VON DER Aa R
    Z Urol; 1963 Nov; 56():411-6. PubMed ID: 14110561
    [No Abstract]   [Full Text] [Related]  

  • 25. [Liquid brucellar allergen in the combined treatment of brucellosis patients].
    Kurmanova KB; Satybaldieva ZhA; Zhurina EV
    Ter Arkh; 1991; 63(11):80-2. PubMed ID: 1810072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans.
    Bundle DR; McGiven J
    Acc Chem Res; 2017 Dec; 50(12):2958-2967. PubMed ID: 29219305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of hydroxychloroquine on treatment and recurrence of acute brucellosis: a single-blind, randomized clinical trial.
    Majzoobi MM; Hashemi SH; Mamani M; Keramat F; Poorolajal J; Ghasemi Basir HR
    Int J Antimicrob Agents; 2018 Mar; 51(3):365-369. PubMed ID: 28826825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
    Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
    Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of laboratory diagnosis on brucellosis therapy.
    Al Dahouk S; Nöckler K
    Expert Rev Anti Infect Ther; 2011 Jul; 9(7):833-45. PubMed ID: 21810055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Increasing the effectiveness of antibiotic therapy by correcting immunologic disorders with vitamin A in patients with brucellosis].
    Kurmanova KB; Ishchanova RZh; Sakhisheva SSh; Studentsova VK; Tsirel'son LE; Alshinbaeva GU
    Antibiot Khimioter; 1990 Jul; 35(7):35-8. PubMed ID: 2126706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New therapeutic method of human brucellosis; aureomycin therapy].
    MOLINELLI EA; PANDOLFO GP; SCHULTE O; ITHURRALDE D; REPETTO OM; BASSO G; MIYARA S; SPERONI A; THOMPSON VE; VITAL VC
    Dia Med; 1950 Dec; 22(76):3307-62. PubMed ID: 14793347
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis.
    Keramat F; Ranjbar M; Mamani M; Hashemi SH; Zeraati F
    Trop Doct; 2009 Oct; 39(4):207-10. PubMed ID: 19762571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis].
    Solera J; Medrano F; Rodríguez M; Geijo P; Paulino J
    Med Clin (Barc); 1991 May; 96(17):649-53. PubMed ID: 1905372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of human brucellosis with rifampicin].
    Godeau P; Fuchs G; Guillevin L; Philippon A; Tucat G; Cabane J; Herson S
    Sem Hop; 1984 Jan; 60(1):5-9. PubMed ID: 6320435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A model of animal-human brucellosis transmission in Mongolia.
    Zinsstag J; Roth F; Orkhon D; Chimed-Ochir G; Nansalmaa M; Kolar J; Vounatsou P
    Prev Vet Med; 2005 Jun; 69(1-2):77-95. PubMed ID: 15899298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted prevention of brucellosis in cattle, sheep, and goats in the Russian Federation.
    Sklyarov O; Shumilov K; Klimanov A; Denisov A
    Vaccine; 2010 Oct; 28 Suppl 5():F54-8. PubMed ID: 20362202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confronting the barriers to develop novel vaccines against brucellosis.
    Oliveira SC; Giambartolomei GH; Cassataro J
    Expert Rev Vaccines; 2011 Sep; 10(9):1291-305. PubMed ID: 21919619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of conventional castaneda and lysis centrifugation blood culture techniques for diagnosis of human brucellosis.
    Mantur BG; Mangalgi SS
    J Clin Microbiol; 2004 Sep; 42(9):4327-8. PubMed ID: 15365036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on treatment options for spinal brucellosis.
    Ulu-Kilic A; Karakas A; Erdem H; Turker T; Inal AS; Ak O; Turan H; Kazak E; Inan A; Duygu F; Demiraslan H; Kader C; Sener A; Dayan S; Deveci O; Tekin R; Saltoglu N; Aydın M; Horasan ES; Gul HC; Ceylan B; Kadanalı A; Karabay O; Karagoz G; Kayabas U; Turhan V; Engin D; Gulsun S; Elaldı N; Alabay S
    Clin Microbiol Infect; 2014 Feb; 20(2):O75-82. PubMed ID: 24118178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic treatment of brucellosis].
    Bertrand A
    Presse Med; 1994 Jun; 23(24):1128-31. PubMed ID: 7971834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.